28.09.2017
- Daniel Mueller: The most obvious effect of consolidation in the pharmaceutical industry is a pronounced shift to those activities within the organization that provide the most...
28.09.2017
- Will the consolidation in the pharmaceutical industry level off at any time soon or is it here to stay and will even intensify? Elliott Berger: With the ever-increasing share of...
28.09.2017
- Drug development/manufacturing projects between pharma companies and CDMOs are based on mutual trust and a focus on success. What do the outsourcing partners have to do in order to...
28.09.2017
- Jane Griffiths: Consolidation in the pharma industry is here to stay: as market competition increases, M&As are one of the fastest ways for companies to obtain critical mass...
28.09.2017
- Will the consolidation in the pharmaceutical industry level off at any time soon or is it here to stay and will even intensify? Marcus Hannakam: We think consolidation will proceed...
28.09.2017
- Drug development/manufacturing projects between pharma companies and CDMOs are based on mutual trust and a focus on success. How big of an issue is a merger or an acquisition for...
28.09.2017
- Will the consolidation in the pharmaceutical industry level off at any time soon or is it here to stay and will it even intensify? Denis Angioletti: Consolidation in the pharma...
28.09.2017
- Challenges caused by a merger or an acquisition can be manifold, no matter whether it is your own organization that is going through M&A and the integration phase or any of your...
